Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorWinthrop, Kevin
dc.contributor.authorYndestad, Arne
dc.contributor.authorHenrohn, Dan
dc.contributor.authorDanese, Silvio
dc.contributor.authormarsal, sara
dc.contributor.authorGalindo, Maria
dc.date.accessioned2023-07-07T12:07:32Z
dc.date.available2023-07-07T12:07:32Z
dc.date.issued2023-04
dc.identifier.citationWinthrop KL, Yndestad A, Henrohn D, Danese S, Marsal S, Galindo M, et al. Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs. Rheumatol Ther. 2023 Apr;10:357–73.
dc.identifier.issn2198-6576
dc.identifier.urihttps://hdl.handle.net/11351/9991
dc.descriptionGrip; Artritis psoriàsica; Colitis ulcerosa
dc.description.sponsorshipThis study was sponsored by Pfizer. Medical writing support was funded by Pfizer. The journal’s Rapid Service Fee for this article was also funded by Pfizer.
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofseriesRheumatology and Therapy;10
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectGrip - Complicacions
dc.subjectProteïnes quinases - Inhibidors
dc.subjectArtritis reumatoide
dc.subject.meshInfluenza, Human
dc.subject.mesh/complications
dc.subject.meshArthritis, Rheumatoid
dc.subject.meshProtein Kinase Inhibitors
dc.titleInfluenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1007/s40744-022-00507-z
dc.subject.decsgripe humana
dc.subject.decs/complicaciones
dc.subject.decsartritis reumatoide
dc.subject.decsinhibidores de proteínas cinasas
dc.relation.publishversionhttps://doi.org/10.1007/s40744-022-00507-z
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Winthrop KL] School of Medicine, Oregon Health and Science University, Portland, USA. [Yndestad A] Pfizer Inc, Oslo, Norway. [Henrohn D] Pfizer AB, Sollentuna, Sweden. Department of Medical Sciences, Uppsala University, Uppsala, Sweden. [Danese S] Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy. [Marsal S] Servei de Reumatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Galindo M] Rheumatology Unit, Hospital Universitario, 12 de Octubre, Madrid, Spain
dc.identifier.pmid36526796
dc.identifier.wos000899877000001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple